Response to Letter to the Editor.
作者信息
Aldaas Omar M, Mylavarapu Praneet S, Hsu Jonathan C
机构信息
Division of Cardiac Electrophysiology at the University of California San Diego Health System, La Jolla, California, USA.
出版信息
Clin Cardiol. 2024 Feb;47(2):e24202. doi: 10.1002/clc.24202. Epub 2023 Dec 19.
Abstract
摘要
相似文献
1
Response to Letter to the Editor.对编辑来信的回复。
Clin Cardiol. 2024 Feb;47(2):e24202. doi: 10.1002/clc.24202. Epub 2023 Dec 19.
2
Authors' response to letter to the editor, letter to the editor: Authors' response to letter to the editor: Safety concerns with human papilloma virus immunization in Japan: Analysis and evaluation of Nagoya City's surveillance data for adverse events.作者对编辑来信的回复，编辑来信：作者对编辑来信的回复：日本人类乳头瘤病毒免疫接种的安全性问题：名古屋市不良事件监测数据的分析与评估
Jpn J Nurs Sci. 2020 Jan;17(1):e12310. doi: 10.1111/jjns.12310. Epub 2019 Dec 2.
3
An article on "letter to the editor".一篇关于“致编辑的信”的文章。
J Oral Maxillofac Pathol. 2023 Apr-Jun;27(2):254-256. doi: 10.4103/jomfp.jomfp_65_23. Epub 2023 Jul 13.
4
Letter to the Editor - The implications of the professionalization of health promotion in Canada: a response to JR Graham's letter to the editor.给编辑的信——加拿大健康促进专业化的影响：对 JR Graham 给编辑的信的回应。
Health Promot Chronic Dis Prev Can. 2017 May;37(5):172-173. doi: 10.24095/hpcdp.37.5.05.
5
Letter #1 Response to letter to Editor by Dr. Sarkar et al. for' who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for' is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?' Refers to PII: S2210-7789(21)00538-9.信件1：对Sarkar博士等人致编辑的信的回复，信的主题为“谁说区分先兆子痫和新冠病毒感染很容易？”，涉及编号：S2210 - 7789(21)00539 - 0
信件2：对Hantoushzadeh博士等人致编辑的信的回复，信的主题为“新冠病毒疾病是先兆子痫的危险因素吗？这些患者是否应考虑使用阿司匹林预防先兆子痫？”，涉及编号：S2210 - 7789(21)00538 - 9
Pregnancy Hypertens. 2022 Mar;27:94-95. doi: 10.1016/j.preghy.2021.11.002. Epub 2021 Nov 25.
6
How to write an editorial letter?如何撰写编辑信函？
Turk J Urol. 2013 Sep;39(Suppl 1):41-3. doi: 10.5152/tud.2013.053.
7
Authors' response to a letter to the editor IJPORL-D-20-01778: Response to a Letter to the Editor.作者对致编辑的一封信（IJPORL-D-20-01778）的回复：对致编辑信件的回复
Int J Pediatr Otorhinolaryngol. 2021 Jan 28:110633. doi: 10.1016/j.ijporl.2021.110633.
8
LETter To the EditoR Standards (LETTERS): Considerations for Authors, Reviewers, and Editors.致编辑的信：标准（信件）：作者、审稿人和编辑须知
J Korean Med Sci. 2024 Sep 30;39(37):e296. doi: 10.3346/jkms.2024.39.e296.
9
Reply to Letter to the Editor: Author Response to Letter to the Editor.致编辑信件的回复：作者对致编辑信件的回应。
J Am Acad Orthop Surg. 2023 Feb 1;31(3):e133-e134. doi: 10.5435/JAAOS-D-21-00805. Epub 2021 Sep 16.
10
Letter to the Editor Re: Author's Response to Letter to the Editor.致编辑的信：关于作者对致编辑信件的回复
Arch Phys Med Rehabil. 2020 Jun;101(6):1096-1097. doi: 10.1016/j.apmr.2019.12.022. Epub 2020 Mar 7.
本文引用的文献
1
Safety and efficacy of catheter ablation of atrial fibrillation in the very elderly (≥80 years old): Insights from the UC San Diego AF Ablation Registry.高龄（≥80 岁）患者行导管消融治疗心房颤动的安全性和有效性：来自加州大学圣地亚哥房颤消融登记研究的结果。
Clin Cardiol. 2023 Dec;46(12):1488-1494. doi: 10.1002/clc.24137. Epub 2023 Aug 25.
2
Cryoballoon ablation for atrial fibrillation in octogenarians: a propensity score-based analysis with a younger cohort.冷冻球囊消融治疗 80 岁以上患者心房颤动：基于倾向评分的与年轻队列比较的分析。
J Cardiovasc Med (Hagerstown). 2023 Jul 1;24(7):441-452. doi: 10.2459/JCM.0000000000001486.
3
Safety and long-term efficacy of cryoballoon ablation for atrial fibrillation in octogenarians: a multicenter experience.高龄患者行冷冻球囊消融治疗心房颤动的安全性和长期疗效：多中心经验。
J Interv Card Electrophysiol. 2022 Nov;65(2):559-571. doi: 10.1007/s10840-022-01313-x. Epub 2022 Jul 22.
Zotero 插件